Salam Sharfaraz, Mihalova Tatiana, Ustianowski Andrew, McKee David, Siripurapu Rehka
Department of Neurology, Salford Royal NHS Foundation Trust, Salford, UK Pennine Acute Hospitals NHS Trust, Manchester, UK.
Department of Neurology, Salford Royal NHS Foundation Trust, Salford, UK.
BMJ Case Rep. 2016 Jun 22;2016:bcr2016214961. doi: 10.1136/bcr-2016-214961.
CD8+ encephalitis (CD8+E) is an emerging and incompletely understood HIV-associated neurological syndrome, typically presenting as a steroid-responsive subacute encephalopathy with prominent white matter changes in patients with apparently well-controlled HIV infection. Some cases can be associated with the phenomenon of 'viral escape' (disproportionate replication within the cerebrospinal fluid), but the most important pathophysiology of CD8+E is thought to involve an attack on HIV-infected CD4+ lymphocytes by autoreactive CD8+ cells. We report a case of CD8+E where the initial positive response to steroid treatment was followed by several relapses on withdrawal. This led to the use of mycophenolate mofetil (MMF) as a long-term steroid-sparing agent, which is the first time this approach has been reported in the literature. The patient has now been on treatment with MMF for 10 months and it has been possible to taper the steroids down to a minimal maintenance dose without further relapse.
CD8+ 脑炎(CD8+E)是一种新出现且尚未完全被理解的与HIV相关的神经综合征,通常表现为在HIV感染明显得到控制的患者中出现对类固醇有反应的亚急性脑病,并伴有显著的白质改变。一些病例可能与“病毒逃逸”现象(脑脊液内不成比例的复制)有关,但CD8+E最重要的病理生理学机制被认为涉及自身反应性CD8+细胞对HIV感染的CD4+淋巴细胞的攻击。我们报告了一例CD8+E病例,该病例最初对类固醇治疗有阳性反应,但停药后多次复发。这导致使用霉酚酸酯(MMF)作为长期的类固醇替代药物,这是该方法首次在文献中被报道。该患者现已接受MMF治疗10个月,并且已能够将类固醇逐渐减量至最小维持剂量而无进一步复发。